JQA Partners
Advertising Networks · California, United States · 1-10 Employees
View Company Info for Free
Overview
Headquarters
6753 Frenata Pl, Carlsbad, California, 9...Phone Number
(917) 885-7378Website
www.jqapartners.comRevenue
<$5 MillionIndustry
ZI Rank: 1
Signal Type
Dec
Jan
Feb
Mar
Apr
May
ZI Rank
1
1
1
1
1
1
About JQA Partners
JQA PARTNERS specializes in strategic communications, focusing on sectors such as healthcare and life sciences. They offer services in investor relations and media relations. Their intended clients include organizations within these industries seeking to enhance their communication strategies. The company aims to guide clients in navigating their communication challenges effectively.Explore more
Popular SearchesJqa Partners IncJqa Partners LLCJqa LLCJqa PartnersJqapartnersSIC Code 87,874NAICS Code 54,541Show moreJQA Partners Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is JQA Partners your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Check if JQA Partners has recently received funding, and reach out quickly before it becomes old news!
JQA Partners, which may be a good buyer, showed buying intent in Masked Content Topic
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Product Launch: Get notified when JQA Partners launches new products
Check out if JQA Partners is spiking on competitors!
Funding: Get notified immidiatlly once JQA Partners has new funding data
Click to see if JQA Partners had a recent Job posting/layoffs
Earning: See what the market has to say on JQA Partners recently announced quarterly report
Website visits: Recent activity has been detected on your website
Congratulate Masked Content for being promoted to Masked Content at JQA Partners
Recommended Actions
Find VP level buyers at JQA Partners
Find 2 more new buyers
Compare Similar Companies to JQA Partners
Compare insights from companies similar to JQA Partners, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Company Profile Activity
Activity Insights
JQA Partners is experiencing very low activity levels compared to other companies in the Business Services sector.
What does this means?
JQA Partners is drawing exceptional interest within the Business Services industry, suggesting notable developments or strong market momentum, learn more about JQA Partners.
JQA Partners Tech Stack
A closer look at the technologies used by JQA Partners
JQA Partners News & Media
Vaccinex, Inc. Gives Podium Presentation and Poster at the Society for Immunotherapy of Cancer Annual Meeting
Company Reviews Mechanism of Action, Preclinical Outcomes and Phase 1 Safety Results of VX15 (pepinemab) as Single Agent and In Combination Therapy Against Multiple Cancers ROCHESTER, N.Y., Nov. 15, 2018 (GLOBE NEWSWIRE) -- Vaccinex, Inc. (Nasdaq: VCNX), a clinical-stage biotechnology company engaged in the discovery and development of targeted biotherapeutics to treat serious diseases and conditions with unmet medical needs, including cancer, neurodegenerative diseases, and autoimmune disordersCHF Solutions Launches Educational Webinar Discussing the Benefits of Aquadex FlexFlow® Therapy Following Cardiovascular Surgery with Cardiovascular Surgeon, Daniel Beckles, M.D., Ph.D.
EDEN PRAIRIE, Minn., Nov. 15, 2018 (GLOBE NEWSWIRE) -- CHF Solutions, Inc. (Nasdaq: CHFS), today announces the launch of its new educational webinar featuring Daniel Beckles, M.D., Ph.D., director of Minimally Invasive Cardiothoracic Surgery at UHS Heart and Vascular Institute, Vestal, N.Y. The webinar can be accessed on the company’s website, www.chf-solutions.com.Vaccinex, Inc. Gives Podium Presentation and Poster at the Society for Immunotherapy of Cancer Annual Meeting
Company Reviews Mechanism of Action, Preclinical Outcomes and Phase 1 Safety Results of VX15 (pepinemab) as Single Agent and In Combination Therapy Against Multiple CancersVaccinex Reports Third Quarter 2018 Financial Results and Provides Corporate Update
Lead candidate pepinemab (VX15) being evaluated in three ongoing clinical trials in cancer and Huntington’s Disease Enrollment in CLASSICAL Lung Cancer trial and Cohort B of the SIGNAL Huntington’s Disease trial is On-Track; Data Expected for NSCLC in 2H 2019 and for Huntington’s disease in 2H 2020 ROCHESTER, N.Y., Nov. 13, 2018 (GLOBE NEWSWIRE) -- Vaccinex, Inc. (NASDAQ: VCNX), a clinical-stage biotechnology company engaged in the discovery and development of targeted biotherapeutics to treat s
Read more news
Top Advertising Networks Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding JQA Partners
Sign Up For FreeTo access detailed company insights
JQA PARTNERS specializes in strategic communications, focusing on sectors such as healthcare and life sciences. They offer services in investor relations and media relations. Their intended clients include organizations within these industries seeking to enhance their communication strategies. The company aims to guide clients in navigating their c... Read More
